A detailed history of Squarepoint Ops LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 26,987 shares of CAPR stock, worth $434,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,987
Holding current value
$434,760
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$12.9 - $21.99 $348,132 - $593,444
26,987 New
26,987 $373,000
Q2 2024

Aug 14, 2024

BUY
$4.63 - $7.09 $105,077 - $160,907
22,695 New
22,695 $108,000

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $392M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.